Expression and distribution of Src in the nucleus of myocytes in cardiac hypertrophy

被引:8
作者
Chen, Ping [1 ]
Li, Faqian [2 ]
Xu, Zeqing [1 ]
Li, Zhanyu [1 ]
Yi, Xian Ping [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Zhuhai 519000, Guangdong, Peoples R China
[2] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA
关键词
cardiac hypertrophy; cell signaling; heart failure; hypertension; Src kinase; FOCAL ADHESION KINASE; HYPERTENSIVE HEART-DISEASE; RAT VENTRICULAR MYOCYTES; BINDING PROTEIN SAM68; NUCLEOLAR PROTEIN; GENE-EXPRESSION; HELA-CELLS; C-SRC; ASSOCIATION; FIBRILLARIN;
D O I
10.3892/ijmm.2013.1382
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The Src kinase is involved in signaling events leading to cardiac hypertrophy. The exact effects of tyrosine phosphorylation and subnuclear distribution on cardiac hypertrophy and failure remain to be investigated. In this study, we examined the intranuclear expression and distribution of c-Src, Src phosphorylated at tyrosine 529 (Src[pY529]), Src phosphorylated at tyrosine 418 (Src[pY418]) and Src phosphorylated at tyrosine 215 (Src[pY215]) in the myocardial nuclei of the left ventricle (LV) from 2-, 6-, 12- and 18-month-old spontaneously hypertensive heart failure (SHHF) rats and age-matched Wistar-Kyoto (WKY) rats as normotensive controls by western blot analysis, immunofluorescent labeling and immunoprecipitation. Cellular Src (c-Src) expression in the myocardial nuclei of the LV of the 2-, 6-, 12- and 18-month-old SHHF rats was not significantly different from that in the myocardial nuclei of the LV of the age-matched WKY rats. Although there were no significant differences observed between the levels of Src[pY529] and Src[pY418] in the myocardial nuclei of the LV of the 2-month-old SHHF and WKY rats, the expression of Src[pY529] significantly decreased, while that of Src[pY418] significantly increased in the myocardial nuclei of the LV of the 6-, 12- and 18-month-old SHHF rats compared to the age-matched WKY controls. Furthermore, as demonstrated by double labeling with antibodies against fibrillarin and Src-associated in mitosis 68 kDa (Sam68), c-Src was co-localized with both Sam68 and fibrillarin in the nuclei; Src[pY529] co-localized with fibrillarin, but Src[pY418] co-localized with Sam68. The results from the present study suggest that the dephosphorylation of Src tyrosine kinase 529, the phosphorylation of tyrosine 418 and their subnuclear redistribution are involved in endonuclear signal transduction in cardiac myocytes, which regulates the development and progression of LV eccentric hypertrophy induced by hypertension.
引用
收藏
页码:165 / 173
页数:9
相关论文
共 50 条
  • [31] Multiple chromatin modifications important for gene expression changes in cardiac hypertrophy
    Bingham, A. J.
    Ooi, L.
    Wood, I. C.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2006, 34 : 1138 - 1140
  • [32] Aldosterone Induced Cardiac Hypertrophy in Rats by Regulating the Expression of Calcineurin Inhibitor
    Li, Zhaohui
    Xie, Xiaohua
    Liu, Li
    Chen, Wen
    Deng, Zhaoyang
    LATIN AMERICAN JOURNAL OF PHARMACY, 2014, 33 (08): : 1321 - 1325
  • [33] Myocardial Gene Expression Associated with Genetic Cardiac Hypertrophy in the Absence of Hypertension
    Jeremy P Dwyer
    Matthew E Ritchie
    Gordon K Smyth
    Stephen B Harrap
    Lea M D Delbridge
    Andrea A Domenighetti
    Robert Di Nicolantonio
    Hypertension Research, 2008, 31 : 941 - 955
  • [34] Expression Profile of Circulating MicroRNAs in Dogs With Cardiac Hypertrophy: A Pilot Study
    Ro, Woong-Bin
    Kang, Min-Hee
    Song, Doo-Won
    Lee, Sung-Hun
    Park, Hee-Myung
    FRONTIERS IN VETERINARY SCIENCE, 2021, 8
  • [35] Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines
    Kang, Yu-Ming
    Zhang, Dong-Mei
    Yu, Xiao-Jing
    Yang, Qing
    Qi, Jie
    Su, Qing
    Suo, Yu-Ping
    Yue, Li-Ying
    Zhu, Guo-Qing
    Qin, Da-Nian
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2014, 274 (03) : 436 - 444
  • [36] Inhibition of NF-κB activity in the hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress
    Yu, Xiao-Jing
    Zhang, Dong-Mei
    Jia, Lin-Lin
    Qi, Jie
    Song, Xin-Ai
    Tan, Hong
    Cui, Wei
    Chen, Wensheng
    Zhu, Guo-Qing
    Qin, Da-Nian
    Kang, Yu-Ming
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2015, 284 (03) : 315 - 322
  • [37] The First Line of Defense Against Cardiac Hypertrophy
    Fan, X.
    Wu, X.
    CURRENT MOLECULAR MEDICINE, 2013, 13 (04) : 670 - 680
  • [38] Tafazzin knockdown causes hypertrophy of neonatal ventricular myocytes
    He, Quan
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2010, 299 (01): : H210 - H216
  • [39] Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes
    Zheng, JS
    Boluyt, MO
    Long, XL
    ONeill, L
    Lakatta, EG
    Crow, MT
    CIRCULATION RESEARCH, 1996, 78 (04) : 525 - 535
  • [40] Redox signaling in cardiac myocytes
    Santos, Celio X. C.
    Anilkumar, Narayana
    Zhang, Min
    Brewer, Alison C.
    Shah, Ajay M.
    FREE RADICAL BIOLOGY AND MEDICINE, 2011, 50 (07) : 777 - 793